Businesses

We believe our portfolio best meets the varied and often complex needs of patients and societies. Novartis is positioned to lead in innovation, partner with others and offer solutions to patients across a broad healthcare spectrum. In addition, a diverse portfolio reduces financial risk, bringing greater value to those who invest in our company.

Novartis has been transformed since its creation in 1996 - when only 45% of net sales came from healthcare - into a leader focused on fast-growing areas of healthcare.

 

 

Novartis is currently organized into four divisions:

• Pharmaceuticals: Innovative patent-protected medicines
• Vaccines and Diagnostics: Human vaccines and diagnostic tools to protect against life-threatening diseases
• Sandoz: Generic pharmaceuticals that replace branded medicines after patent expiry and free up funds for innovative medicines
• Consumer Health: Readily available products that enable healthy lifestyle choices: OTC (Over-the-Counter), Animal Health and CIBA Vision.